Skip to main content
SpringerLink
Log in

Prescribing for chronic heart failure (HF) in Europe is largely influenced by a patient's country,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Sturm HB, van Gilst WH, Veeger N, Haaijer-Ruskamp FM.Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey. Pharmacoepidemiology and Drug Safety 16: 96-103, No. 1, Jan 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prescribing for chronic heart failure (HF) in Europe is largely influenced by a patient's country,. Pharmacoecon. Outcomes News 527, 8 (2007). https://doi.org/10.1007/BF03309419

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309419

Keywords

Search

Navigation